The Canadian Health Information Management Association (CHIMA) represents approximately 5,000 Health Information Management (HIM®) professionals across Canada and is the certifying body and national association that represents leadership and excellence in health information management. CHIMA supports continuing education and professional practice of HIM professionals, develops strategic partnerships to advance the development and integration of electronic HIM, and advocates for and strengthens the HIM role in health care settings across the continuum of care.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Medical

AGILENT ANNOUNCES COLLABORATION WITH APC ON REAL-TIME PROCESS MONITORING

Agilent Technologies | May 31, 2022

news image

Agilent Technologies Inc. (NYSE: A) today announced a collaboration agreement with APC Ltd., in which the companies commit to working towards combining their technologies to provide unique workflows to customers that support automated process analysis via liquid chromatography (LC). Agilent has selected to partner with APC, a provider of innovative small molecule and large molecule process design and process development solutions. Both APC and Agilent pursue similar goals, which a...

Read More

Industrial Impact

ALLOY THERAPEUTICS AND NORMUNITY SIGN MULTI-PROGRAM ANTIBODY DISCOVERY COLLABORATION IN IMMUNO-ONCOLOGY

Alloy Therapeutics | November 18, 2022

news image

Alloy Therapeutics, a biotechnology ecosystem company, announced an antibody discovery collaboration spanning multiple precision immuno-oncology programs for Normunity, a biotech company that recently announced its $65 million Series A financing. The collaboration will support the advancement of Normunity’s immune normalizers, antibody therapies designed to target novel mechanisms that free the body’s normal immunity to fight cancer, which are conceived through a unique biotech-acade...

Read More

Medical

DNA-ENCODED LIBRARIES (DELS) AND NANOBRET TARGET ENGAGEMENT ASSAYS ACCELERATE DRUG DISCOVERY

Businesswire | August 03, 2023

news image

A new study demonstrates how the combination of DNA-encoded libraries (DELs) and NanoBRET Target Engagement technology can accelerate early-stage drug discovery. Reported in Cell Chemical Biology, researchers from Promega Corporation and WuXi AppTec generated new chemical probes from molecules identified through a DEL screen. This research opens new opportunities to develop novel NanoBRET Target Engagement Assays aimed at many understudied classes of proteins, rapidly accelerating “h...

Read More

Research

SYNTHACE UNVEILS FIRST LIFE SCIENCES R&D CLOUD ADDRESSING COMPLEXITY, SPEED & REPRODUCIBILITY FOR SCIENTISTS

Synthace | August 03, 2021

news image

Synthace, a leading life sciences software company, today announced the first life sciences R&D cloud that includes a no-code software platform addressing the largest barriers to innovation that R&D life scientists currently face. With the release of this new platform, Synthace is also the first vendor to enable scientists to automate experimentation and insight sharing in a unified, global R&D environment. Scientists can now focus on asking the most impactful questions and unlock th...

Read More
news image

Medical

AGILENT ANNOUNCES COLLABORATION WITH APC ON REAL-TIME PROCESS MONITORING

Agilent Technologies | May 31, 2022

Agilent Technologies Inc. (NYSE: A) today announced a collaboration agreement with APC Ltd., in which the companies commit to working towards combining their technologies to provide unique workflows to customers that support automated process analysis via liquid chromatography (LC). Agilent has selected to partner with APC, a provider of innovative small molecule and large molecule process design and process development solutions. Both APC and Agilent pursue similar goals, which a...

Read More
news image

Industrial Impact

ALLOY THERAPEUTICS AND NORMUNITY SIGN MULTI-PROGRAM ANTIBODY DISCOVERY COLLABORATION IN IMMUNO-ONCOLOGY

Alloy Therapeutics | November 18, 2022

Alloy Therapeutics, a biotechnology ecosystem company, announced an antibody discovery collaboration spanning multiple precision immuno-oncology programs for Normunity, a biotech company that recently announced its $65 million Series A financing. The collaboration will support the advancement of Normunity’s immune normalizers, antibody therapies designed to target novel mechanisms that free the body’s normal immunity to fight cancer, which are conceived through a unique biotech-acade...

Read More
news image

Medical

DNA-ENCODED LIBRARIES (DELS) AND NANOBRET TARGET ENGAGEMENT ASSAYS ACCELERATE DRUG DISCOVERY

Businesswire | August 03, 2023

A new study demonstrates how the combination of DNA-encoded libraries (DELs) and NanoBRET Target Engagement technology can accelerate early-stage drug discovery. Reported in Cell Chemical Biology, researchers from Promega Corporation and WuXi AppTec generated new chemical probes from molecules identified through a DEL screen. This research opens new opportunities to develop novel NanoBRET Target Engagement Assays aimed at many understudied classes of proteins, rapidly accelerating “h...

Read More
news image

Research

SYNTHACE UNVEILS FIRST LIFE SCIENCES R&D CLOUD ADDRESSING COMPLEXITY, SPEED & REPRODUCIBILITY FOR SCIENTISTS

Synthace | August 03, 2021

Synthace, a leading life sciences software company, today announced the first life sciences R&D cloud that includes a no-code software platform addressing the largest barriers to innovation that R&D life scientists currently face. With the release of this new platform, Synthace is also the first vendor to enable scientists to automate experimentation and insight sharing in a unified, global R&D environment. Scientists can now focus on asking the most impactful questions and unlock th...

Read More

Resources

resource image

Industry Outlook

Biopharmaceutical Sector

Whitepaper

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us